CARR vs EBS
Carrier Global Corp (CARR) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CARR and EBS stock pages for the full models.
Not investment advice.